(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Four Dead in Last Month From Animal Attacks in Nepal - 2Addressing sleep apnea early might decrease chances of developing Parkinson's disease
- 3How to sound like an astronaut as you follow the first human moon mission in more than half a century
- 4Illumina unveils dataset to speed up AI-powered drug discovery
- 5Make your choice for the music application with the most amicable connection point!
- Women take pride in Holy Week roles after a Spanish Catholic brotherhood's procession excluded them
- Figure out How to Augment Eco-friendliness in Your Volvo XC40
- Find the Techniques for Powerful Review Propensities: Opening Your Scholarly Potential
- Dozens injured in Russia after train crashes, overturns
- Becoming amazing at Systems administration: Individual and Expert Tips
- IDF bans Android phones for senior officers, iPhones now mandatory, Army Radio reports
- Lift Your Style: Famous Hairdos for Ladies
- When does Spotify Wrapped come out? The music streamer says 'soon.'
- JFK's granddaughter Tatiana Schlossberg reveals terminal cancer diagnosis
